ResearcherSapporo Medical UniversityActive in the last 2 years
Tatsuya Ito
Matched on ORCID iD 0009-0009-8658-8012; OpenAlex author ID A5085733466. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2011: 3 papers · 2012: none · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Concordance of claudin-18.2 expression in biopsy, resection, and recurrent specimens: implications for zolbetuximab therapy in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/21688370.2025.2535047↗
- Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway. Co-author DOI 10.1002/prp2.196↗
- Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pancreatic cancer. Co-author DOI 10.1093/carcin/bgt057↗
- Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells. Co-author DOI 10.1002/jcb.23095↗
- Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. Co-author DOI 10.1007/s00441-011-1287-2↗
- Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human pancreatic cancer cells. Co-author DOI 10.1016/j.yexcr.2011.06.020↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daisuke Kyuno · 6 shared papers, 2011–2026 · strength 0.49
- Paper Concordance of claudin-18.2 expression in biopsy, resection, and recurrent specimens: implications for zolbetuximab the… DOI 10.1080/21688370.2025.2535047↗
- Paper Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway. DOI 10.1002/prp2.196↗
- Paper Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pa… DOI 10.1093/carcin/bgt057↗
- Masafumi Imamura · 4 shared papers, 2011–2026 · strength 0.44
- Paper Concordance of claudin-18.2 expression in biopsy, resection, and recurrent specimens: implications for zolbetuximab the… DOI 10.1080/21688370.2025.2535047↗
- Paper Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway. DOI 10.1002/prp2.196↗
- Paper Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pa… DOI 10.1093/carcin/bgt057↗
- Makoto Osanai · 1 shared paper, 2026 · strength 0.33
- Norimasa Sawada · 5 shared papers, 2011–2015 · strength 0.15
- Paper Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway. DOI 10.1002/prp2.196↗
- Paper Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pa… DOI 10.1093/carcin/bgt057↗
- Paper Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens e… DOI 10.1007/s00441-011-1287-2↗
- Takashi Kojima · 5 shared papers, 2011–2015 · strength 0.15
- Paper Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway. DOI 10.1002/prp2.196↗
- Paper Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pa… DOI 10.1093/carcin/bgt057↗
- Paper Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens e… DOI 10.1007/s00441-011-1287-2↗
- Koichi Hirata · 5 shared papers, 2011–2015 · strength 0.15
- Paper Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway. DOI 10.1002/prp2.196↗
- Paper Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pa… DOI 10.1093/carcin/bgt057↗
- Paper Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens e… DOI 10.1007/s00441-011-1287-2↗
- Akira Takasawa · 4 shared papers, 2011–2013 · strength 0.11
- Paper Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pa… DOI 10.1093/carcin/bgt057↗
- Paper Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens e… DOI 10.1007/s00441-011-1287-2↗
- Paper Downregulation of tight junction-associated MARVEL protein marvelD3 during epithelial-mesenchymal transition in human p… DOI 10.1016/j.yexcr.2011.06.020↗
- Yasutoshi Kimura · 3 shared papers, 2011–2015 · strength 0.10
- Paper Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathway. DOI 10.1002/prp2.196↗
- Paper Protein kinase Cα inhibitor protects against downregulation of claudin-1 during epithelial-mesenchymal transition of pa… DOI 10.1093/carcin/bgt057↗
- Paper Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methy… DOI 10.1002/jcb.23095↗
- Takumi Konno · 1 shared paper, 2015 · strength 0.05
- Tsuyoshi Kono · 1 shared paper, 2015 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.